ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Costimulatory Blockade and Allo-Specific Treg Therapy for Liver Transplant Recipients: Preclinical Data

L. Contreras-Ruiz1, K. Shimozawa2, R. Zhang1, L. Turka3, J. F. Markmann3, E. C. Guinan2

1Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 2Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA, 3Center of Transplantation Sciences, Massachussetts General Hosp., Boston, MA

Meeting: 2019 American Transplant Congress

Abstract number: D34

Keywords: Co-stimulation, Liver transplantation, T cells, Tolerance

Session Information

Date: Tuesday, June 4, 2019

Session Name: Poster Session D: Stem Cell, Cellular Therapies and Regenerative Medicine

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall C & D

Related Abstracts
  • Responder B Cell Depletion Increased Allo-Reactive Regulatory T Cells Generated in Allo-Anergization
  • Eomes-Expressing CD8+ T Cells and Th17 Cells Mediate Costimulatory Blockade-Resistant Allograft Rejection in Mice

*Purpose: Adoptive transfer of ex vivo generated donor-specific regulatory T cells (Treg) by using CD28/B7 costimulatory blockade (CSB) to induce transplant (TX) tolerance and minimize use of immunosuppressants (IS) has shown promise in a pilot renal TX study. A new trial in liver TX recipients was designed to use post-TX PBMC as the source of donor-specific Treg generated by ex vivo CSB. However, the immune status of patients on IS after liver TX is incompletely characterized and IS effects on the ability to generate recipient Treg using CSB unknown. We therefore characterized the immune profile of PBMC from liver recipients post-TX and the feasibility donor-specific Treg expansion from those PBMC using an ex vivo CSB strategy.

*Methods: PBMCs were isolated from liver recipients (n=41, age 58±12) 1-4 months post-TX on IS (tacrolimus, mycophenolate mofetil, and prednisone), and from healthy volunteers (n=9). T cell subsets (CD4/CD8, Th1/Th2, Th17/Treg), TCR signaling (pArK, pErk, pS6) and IL-2 production in response to TCR stimulation were evaluated by FACS and PCR. To expand donor-specific Treg, post-TX recipient PBMC were cocultured with healthy donor irradiated PBMC for 72h in the presence of belatacept for CSB. Proliferation was assessed in 1°MLR. Treg expansion was evaluated by FACS after 1°MLR culture and after 2°MLR (to model in vivo re-exposure to alloantigen). Treg function and specificity were studied in suppression assays.

*Results: Except for moderate lymphopenia, the immune status of recipient PBMC post-TX was equivalent to that of healthy volunteers, with no significant differences in CD4/CD8 and Th1/Th2/Th17 subsets. Despite IS, CD3/CD28 stimulation of post-TX PBMC resulted in comparable TCR signaling (phosphorylation levels of Akt, Erk, S6) and IL-2 production. Liver recipients post-TX PBMC had a significantly reduced Treg frequency. However, use of post-TX PBMC during CSB resulted in 1) equivalent inhibition of proliferation in 1°CSB and 2) comparable expansion of functional and allospecific Treg, to that of healthy volunteers.

*Conclusions: The peripheral immune status of liver recipients post-TX appears similar to that of healthy volunteers. Ex vivo expansion of Treg using CSB can be performed using liver recipient post-TX PBMC.

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Contreras-Ruiz L, Shimozawa K, Zhang R, Turka L, Markmann JF, Guinan EC. Costimulatory Blockade and Allo-Specific Treg Therapy for Liver Transplant Recipients: Preclinical Data [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/costimulatory-blockade-and-allo-specific-treg-therapy-for-liver-transplant-recipients-preclinical-data/. Accessed March 1, 2021.

« Back to 2019 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Enhanced Recovery after Surgery Protocols in Kidney Transplantation: Time to Change Practice?
  • Efficacy of Filgrastim in Solid Organ Transplant Recipients
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • #16789 (not found)
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.